In this webinar, experts and members of the Therapeutics Working Group discussed the current status of COVID-19 therapeutics, availability of these expensive medicines in low-resource settings, and research needs to advise and guide health policies.
In this webinar, experts and members of the Therapeutics Working Group discussed the current status of COVID-19 therapeutics, availability of these expensive medicines in low-resource settings, and research needs to advise and guide health policies.